Epigral Ltd share price logo

Meghmani Finechem Share Price

(EPIGRAL)

Check the latest share price of Meghmani Finechem, details on performance, fundamentals, analyst ratings, peer comparison, financials, company news, analysis, and shareholding pattern for informed investing decisions.

₹1834.40.36%

as on 02:41PM, 13 May 2025

NSE

bell
The current prices are delayed by 15 mins, login to check live prices.

Meghmani Finechem Performance

Get real-time share price information, day’s high and low, historical returns and market stats.

  • Day's Low

    Day's High

    ₹1,801.5
    Day's Price Range
    ₹1,871.9
  • 52 Week's Low

    52 Week's High

    ₹1,110.05
    52-Week Price Range
    ₹2,406.75
1 Month Return+ 0.29 %
3 Month Return-1.08 %
1 Year Return+ 47.3 %
3 Year Return+ 53.17 %
5 Year Return+ 352.95 %
Previous Close₹1,841.00
Open₹1,834.30
Volume28.54K
Upper Circuit₹2,209.20
Lower Circuit₹1,472.80

Meghmani Finechem Fundamentals & Key Indicators

Check the fundamental ratios and key indicators of the company like P/E, P/B, PEG, Dividend yield etc.

Market Cap

₹7,942.32 Cr

Return on Equity (ROE)

16.85

PE Ratio (TTM)

21.75

Return on capital employed (ROCE)

17.45

Industry PE ratio

54.11

Beta (LTM)

1.23

P/B Ratio

3.63

Dividend Yield

0.46

PEG Ratio

0.58

Quarterly Earnings Growth YOY

12.45

EPS (TTM)

47.14

Sector

Chemicals

Book Value

301.83

Technical Analysis

How to invest in Meghmani Finechem

Investing in Meghmani Finechem is simple. You can open a free INDstocks investment account on the INDmoney App. Search for Meghmani Finechem or EPIGRAL on the app to check live prices of the stock and click on Buy or SIP. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.

For example: You can buy 10 shares of Meghmani Finechem or start an SIP based on the market price on each investment date.

You can easily transfer money to your stock account via the INDmoney app and start investing in stocks like Meghmani Finechem with just a few clicks!

Meghmani Finechem Stock's Interest Amongst Investors

13%

Period May 13, 2025 to Apr 13, 2025. Change in 30 Days vs previous period

Search interest for Epigral Ltd Stock has increased by 13% in the last 30 days, reflecting an upward trend in search activity.

Meghmani Finechem Valuation

Track how the P/E of Meghmani Finechem has moved over time to understand valuation trends.

Meghmani Finechem in the last 5 years

  • Overview

  • Trends

Lowest (9.04x)

March 28, 2023

Today (21.75x)

May 12, 2025

Industry (54.11x)

May 12, 2025

Highest (38.05x)

September 24, 2024

LowHigh

Today’s Price to Earnings Ratio: 21.75x

Analysts Recommendation on Meghmani Finechem

Get updated buy, sell, and hold recommendations by analysts on Meghmani Finechem.

based on 1 analysts

BUY

100.00%

Buy

0.00%

Hold

0.00%

Sell

100% of analysts recommend a 'BUY' rating for Meghmani Finechem. Average target price of ₹2450

Source: S&P Global Market Intelligence

Analysts Forecast on Meghmani Finechem

Get share price movements and forecasts by analysts on Meghmani Finechem.

Meghmani Finechem price forecast by 1 analysts

Upside of33.08%

High

₹2450

Target

₹2450.00

Low

₹2450

Meghmani Finechem target price ₹2450, a slight upside of 33.08% compared to current price of ₹1834.4. According to 1 analysts rating.

Source: S&P Global Market Intelligence

Meghmani Finechem Financials

Get the annual and quarterly financial summary of Meghmani Finechem, including revenue, profit, loss and more.

Value in ₹ crore
DetailsQ'1 24Q'2 24Q'3 24Q'4 24Q'1 25
Revenue

(in ₹ Cr)

525 (0%)651 (24%)626 (4%)645 (3%)628 (3%)
Net Income

(in ₹ Cr)

77 (0%)86 (11%)81 (5%)104 (27%)87 (16%)
Net Profit Margin14.73% (0%)13.19% (10%)12.99% (2%)16.06% (24%)13.84% (14%)
Value in ₹ crore
Details2021202220232024
Total Assets

(in ₹ Cr)

1449 (0%)2124 (47%)2432 (15%)2794 (15%)
Total Liabilities

(in ₹ Cr)

765 (0%)1187 (55%)1253 (6%)1485 (19%)
Value in ₹ crore
Details20202021202220232024
Operating Cash Flow

(in ₹ Cr)

165 (0%)229 (39%)284 (24%)626 (121%)398 (36%)

Meghmani Finechem Index Inclusions

S&P BSE Commodities

₹7,348.79

-0.65 (-48.24%)

BSE Small-Cap

₹49,042.49

0.72 (348.74%)

Meghmani Finechem Earnings and Dividends

View detailed summary of the earnings and dividend history of Meghmani Finechem.

  • Epigral Ltd Earnings Results

    Epigral Ltd’s net profit jumped 12.45% since last year same period to ₹86.89Cr in the Q4 2024-2025. On a quarterly growth basis, Epigral Ltd has generated -16.15% fall in its net profits since last 3-months.

    Read More about Earnings Results
  • Epigral Ltd Dividends January,2025

    In the quarter ending December 2024, Epigral Ltd has declared dividend of ₹2.50 - translating a dividend yield of 0.41%.

    Read More about Dividends

Meghmani Finechem Shareholding Pattern

View the shareholding pattern breakup of promoters, FIIs, DIIs, and retail investors in Meghmani Finechem.

InvestorsHoldings %Quarterly Trend3M change
Promoter Holdings
68.95%
0.00
Foreign Institutions
3.01%
0.00
Mutual Funds
4.48%
0.00
Retail Investors
23.35%
0.00
Others
0.21%
0.00

Meghmani Finechem vs Peers

Compare market cap, revenue, PE, and other key metrics of Meghmani Finechem with its industry peers.

Company
Analyst View
Market Cap(in ₹ Cr)
5 Year CAGRDebt to Asset Ratio
Net Profit(in ₹ Cr)
Yearly Revenue(in ₹ Cr)
BUY7,942.3270.59%0.711951,929
NA1,519.62640.07%0.50NANA
NA635.108.61%0.754190
NA2,152.79263.41%0.8457593
BUY2,768.2858.04%0.551231,949

Meghmani Finechem News & Key Events

Latest news and events at one place to help you take investing decisions in Meghmani Finechem.

  • Emkay Global Financial Upgrades Epigral Target Price - 06 May, 2025

    Emkay Global Financial maintains a 'BUY' rating on Epigral, raising the target price to Rs 2450. The company reported strong YoY growth in revenue, EBITDA, and PAT, driven by improvements in its caustic soda business and volume growth in derivatives. Capex plans are on track, with a volume growth guidance of 15-20% for the coming years.
  • Epigral Reports Strong Q4 Results and Dividend - 05 May, 2025

    Epigral's Q4 FY25 results show a 13% increase in net profit to Rs 87 crore, with total revenue rising 20% to Rs 631 crore. The company declared a final dividend of Rs 3.5 per share and plans to expand its CPVC and Epichlorohydrin capacity by FY2027, enhancing growth prospects.
  • Epigral Ltd Expands Renewable Energy Initiatives - 23 Apr, 2025

    Epigral Ltd is enhancing its renewable energy usage, sourcing 19 MW of solar and 19 MW of wind energy, meeting 15% of its energy needs. The company aims to increase this share to 25% within two years, highlighting its commitment to sustainability and competitiveness.

Insights on Epigral Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    MF Holding Up

    img

    Mutual Funds have increased holdings from 4.15% to 4.48% in Mar 2025 quarter

  • imgPOSITIVE IMPACT

    Promoter Holding Up

    img

    Promoters have increased holdings from 68.94% to 68.95% in Mar 2025 quarter

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 1 year, EPIGRAL stock has moved up by 47.3%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Solar Industries India Ltd has given 377.5% return, outperforming this stock by 324.3%

  • imgNO EFFECT

    FII Holding Unchanged

    img

    Foreign Institutions holdings remained unchanged at 3.01% of holdings in Mar 2025 quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Solar Industries India Ltd has given 53.2% return, outperforming this stock by 5.9%

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 2 quarters, 103.63 Cr → 86.89 Cr (in ₹), with an average decrease of 16.2% per quarter

  • imgNEGATIVE IMPACT

    Revenue Fall

    img

    Revenue is down for the last 2 quarters, 649.19 Cr → 631.3 Cr (in ₹), with an average decrease of 2.8% per quarter

  • imgNEGATIVE IMPACT

    Retail Holding Down

    img

    Retail Investor have decreased holdings from 23.72% to 23.35% in Mar 2025 quarter

About Meghmani Finechem

Meghmani Finechem Limited was incorporated in 2007 and is primarily engaged in the manufacturing and selling of Chlor Alkali and its Derivatives, as well as Agrochemicals and Pigments trading. Following the approval from the National Company Law Tribunal NCLT Ahmedabad Bench in May 2021, Meghmani Finechem Limited was demerged from Meghmani Organics in FY 2020-21, and is driven by the second generation of the Promoter family. The Company's Chlor Alkali business has grown from an installed capacity of 188,000 TPA in 2015 to 315,000 TPA. Investments in a Caustic Soda, Hydrogen Peroxide and a 36MW Captive Power Plant have further broadened the Company's manufacturing capacity, with the Payback from these investments being recovered in 45 years. In FY 2020-21, the Company announced the implementation of a 50,000TPA manufacturing facility for Epichlorohydrin ECH and 30,000TPA Chlorinated Polyvinyl Chloride CPVC. The facility is based on glycerin feedstock obtained from 100% renewable resources and is expected to be commissioned in the first quarter of the next financial year. The CPVC Resin project of 30,000TPA is likely to be commissioned by the second quarter of FY 2022-23.

Revenue: ₹627.63Cr as on March 2025 (Q1 25)
Net Profit: ₹86.89Cr as on March 2025 (Q1 25)
Listing date: 18 Aug, 2021
Chairperson Name: Maulik Jayantibhai Patel
OrganisationEpigral Ltd
HeadquartersAhmedabad
IndustryChemicals
CEOMaulik Jayantibhai Patel
E-voting on sharesClick here to vote

Indian Mutual Funds that own Meghmani Finechem

Check out the Mutual Funds with significant holdings in Meghmani Finechem.

FAQs

What is Epigral Ltd price today?

Epigral Ltd share price today stands at ₹1834.4, Open: ₹1834.3, Previous Close: ₹1841, High: ₹1871.9, Low: ₹1801.5, 52 Week High: ₹2406.75, 52 Week Low: ₹1110.05.

How to Buy Epigral Ltd Share in India?

  • Get a PAN card
  • Open a Demat account
  • Open a Trading account
  • Link your Demat account to your Trading account
  • Fund your Trading account
  • Place an order to buy Epigral Ltd shares

What are today's traded volumes of Epigral Ltd?

Today's traded volume of Epigral Ltd(EPIGRAL) is 28.54K.

What is today's market capitalisation of Epigral Ltd?

Today's market capitalisation of Epigral Ltd(EPIGRAL) is ₹7,942.32 Cr.

What is the 52 Week High and Low Range of Epigral Ltd?

Epigral Ltd (EPIGRAL)
Price
52 Week High
₹2406.75
52 Week Low
₹1110.05

How much percentage Epigral Ltd is down from its 52 Week High?

Epigral Ltd (EPIGRAL) share price is ₹1834.4. It is down -23.78% from its 52 Week High price of ₹2406.75

How much percentage Epigral Ltd is up from its 52 Week low?

Epigral Ltd (EPIGRAL) share price is ₹1834.4. It is up 65.25% from its 52 Week Low price of ₹1110.05